Correlation between intestinal blOod flow assessed by magNetic resonance imaging and ulTRASound Techniques (CONTRAST)

Phase 1

• Conditions: Crohns Disease with active disease; MedDRA version: 14.1Level: PTClassification code 10059696Term: Scan with contrastSystem Organ Class: 10022891 - Investigations; MedDRA version: 14.1Level: LLTClassification code 10011403Term: Crohn's disease aggravatedSystem Organ Class: 10017947 - Gastrointestinal disorders; MedDRA version: 14.1Level: LLTClassification code 10028049Term: MRISystem Organ Class: 10022891 - Investigations; MedDRA version: 14.1Level: PTClassification code 10045434Term: Ultrasound scanSystem Organ Class: 10022891 - Investigations; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]

• Registration Number: EUCTR2011-005886-19-DK
• Lead Sponsor: Gastroenterology MIDT

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-07-31
• Last Update Posted: 10 August 2021

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Crohns disease in moderate to severe activity.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 24
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 1

Exclusion Criteria

Female subjects who are pregnant or breastfeeding.
Contraindications for MRI with Dotarem
Contraindications for Sonovue
Inflammation not detectable by MRI and US.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified